Clinical trial / 1985
High-dose vitamin C did not improve outcomes in advanced colorectal cancer.
A double-blind randomized trial evaluated 100 chemotherapy-naive patients with advanced colorectal cancer assigned to receive 10 g daily of oral vitamin C or placebo. High-dose vitamin C provided no benefit over placebo for time to disease progression or overall survival. No patients with measurable disease demonstrated objective improvement following vitamin C treatment.
- Study type
- Randomized controlled trial
- Who was studied
- 100 patients with advanced colorectal cancer without prior chemotherapy
- What was measured
- Disease progression, survival, and objective tumor response
THE PAPER
High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison.
Moertel CG, Fleming TR, Creagan ET, Rubin J, O'Connell MJ, Ames MM. N Engl J Med, 1985.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.